We read with interest the Review by Tommaso Gori and colleagues (Predictors of stent thrombosis and their implications for clini cal practice. Nat. Rev. Cardiol. 16, 243-256 (2019)) 1 . The authors present the different risk factors that potentially lead to stent thrombo sis and the new therapies for this condition. One of the risk factors identified for stent thrombosis is stent fracture, with studies by Kuramitsu and colleagues 2 and Kan and colleagues 3 being cited.
In the study by Kuramitsu and colleagues, 1,035 patients with 1,339 lesions treated with everolimus eluting stents were followed up for 6-9 months 2 . The incidence of stent thrombo sis in the stent fracture group was higher than that in the non stent fracture group (5.1% versus 0.4%; P = 0.018). In the study by Kan and col leagues, 6,555 patients with 10,751 lesions treated with a drug eluting stent were followed up for 9-12 months 3 . Again, the incidence of stent thrombosis in the stent fracture group was higher than that in the non stent fracture group (4.60% versus 1.03%; P < 0.05). There fore, Gori and colleagues inferred that stent fracture is associated with stent thrombosis 1 .
However, in a study by Umeda and col leagues, in which 793 patients with 874 lesions treated with a sirolimus eluting stent were followed up for 4 years, no significant differ ence was observed in the incidence of stent thrombosis between the stent fracture group and the non stent fracture group (2.9% versus 0.8%; P = 0.148) 4 . In addition, Nakazawa and colleagues reviewed high contrast, film based radiographs and performed histopathological analysis of 177 consecutive lesions from the CVPath drug eluting stent autopsy registry 5 . Only severe stent fracture (with transection causing a gap in the stent segment) was signif icantly associated with stent thrombosis. In a study of 2,098 patients who had a coronary stent implanted and who underwent follow up coronary angiography at the Second Affiliated Hospital of Nanchang University, China, between 2012 and 2017, eight patients were found to have stent fracture (four con firmed by intravascular ultrasonography). As of 1 December 2018, the mean dura tion of follow up of these eight patients was 903 ± 683 days, and none had developed stent thrombosis (Y.H.R. and R.Q.Y., unpublished observations).
There is a reply to this letter by Gori, T. et al. Nat. Rev. Cardiol. https://doi.org/10.1038/ s4156901902635 (2019).
In summary, stent fracture and stent thrombosis are both rare but severe compli cations of coronary procedures with a very complex pathophysiology, but the relationship between them is still uncertain. The classifi cation of coronary stent fracture, the drug coating of the coronary stent and the dura tion of coronary stent implantation must be carefully considered when exploring the rela tionship between stent fracture and throm bosis. Perhaps with the increasing awareness of stent fracture, new imaging tools such as intravascular ultrasonography and optical coherence tomography will be used to define the relationship between stent fracture and thrombosis. We are grateful to YueHua Ruan and Ren Qiang Yang for their interest in our Review (Predictors of stent thrombosis and their impli cations for clinical practice. Nat. Rev. Cardiol. 16, 243-256 (2019)) 1 and for their helpful comments (Relationship between stent fracture and thrombosis. Nat. Rev. Cardiol. https://doi.org/10.1038/s41569019 02626 (2019)) 2 . We absolutely agree that the relationship between stent strut fracture and thrombosis (as well as restenosis) requires further investigation.
Relationship between stent fracture and stent thrombosis
No agreement exists on the true preval ence of strut rupture, which varies from <1% to 20% in the literature. This variability is influe nced by factors such as time after implan tation, stent type and implantation technique used, and vessel characteristics. Most importantly, the diagno sis of stent fracture is also influ enced by the spatial reso lu tion of the imaging method used. The resolution of either standard radiography or intra vascular ultrasonography does not allow stent fractures to be system atically assessed. Optical coherence tomo graphy also has limitations -for instance, in the setting of stent failure, when blood flushing is often incomplete, and late after stenting, when the visibility of the struts is reduced owing to the presence of neointima. Furthermore, invasive imaging methods provide little infor mation when a stent fracture is not associated with dislodgement of the stent segments.
The discordance between reports also results from the lack of a standardized defini tion of stent fracture. Nakazawa and colleagues propose a classification for this entity on the basis of pathology findings, which unfortu nately cannot be directly applied in routine clinical practice 3 . We agree with Ruan and Yang that such a classification (most likely on the basis of intracoronary imaging evidence) might help to define the strength and the mechanisms of the asso ciation between stent fracture and thrombosis (including whether only 'major' fractures lead to an increased risk of thrombotic or restenotic events).
